$59.17
0.48% today
Nasdaq, Aug 18, 08:18 pm CET
ISIN
US40131M1099
Symbol
GH

Guardant Health, Inc. Stock price

$58.88
+10.79 22.44% 1M
+10.76 22.36% 6M
+28.33 92.73% YTD
+30.34 106.31% 1Y
+3.84 6.98% 3Y
-29.39 33.30% 5Y
+26.68 82.86% 10Y
+26.68 82.86% 20Y
Nasdaq, Closing price Fri, Aug 15 2025
-1.48 2.45%

Key metrics

Basic
Market capitalization
$7.3b
Enterprise Value
$7.8b
Net debt
$486.4m
Cash
$629.1m
Shares outstanding
124.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
8.9 | 8.1
EV/Sales
9.4 | 8.6
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-9.4%
Return on Equity
312.5%
ROCE
-42.1%
ROIC
-76.5%
Debt/Equity
-3.7
Financials (TTM | estimate)
Revenue
$828.9m | $911.7m
EBITDA
$-419.1m | $-228.9m
EBIT
$-460.7m | $-385.5m
Net Income
$-413.8m | $-392.6m
Free Cash Flow
$-272.0m
Growth (TTM | estimate)
Revenue
28.8% | 23.4%
EBITDA
12.0% | 43.0%
EBIT
11.2% | 13.1%
Net Income
15.7% | 10.0%
Free Cash Flow
9.0%
Margin (TTM | estimate)
Gross
62.8%
EBITDA
-50.6% | -25.1%
EBIT
-55.6%
Net
-49.9% | -43.1%
Free Cash Flow
-32.8%
More
EPS
$-3.4
FCF per Share
$-2.2
Short interest
7.9%
Employees
2k
Rev per Employee
$370.0k
Show more

Is Guardant Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,018 stocks worldwide.

Guardant Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

34 Analysts have issued a Guardant Health, Inc. forecast:

30x Buy
88%
3x Hold
9%
1x Sell
3%

Analyst Opinions

34 Analysts have issued a Guardant Health, Inc. forecast:

Buy
88%
Hold
9%
Sell
3%

Financial data from Guardant Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
829 829
29% 29%
100%
- Direct Costs 308 308
20% 20%
37%
521 521
35% 35%
63%
- Selling and Administrative Expenses 625 625
35% 35%
75%
- Research and Development Expense 357 357
2% 2%
43%
-419 -419
12% 12%
-51%
- Depreciation and Amortization 42 42
3% 3%
5%
EBIT (Operating Income) EBIT -461 -461
11% 11%
-56%
Net Profit -414 -414
16% 16%
-50%

In millions USD.

Don't miss a Thing! We will send you all news about Guardant Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Guardant Health, Inc. Stock News

Neutral
Business Wire
3 days ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on July 22, 2025, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units (“RSUs”) representing 239,565 shares of its common stock to 189 new non-executive employees and two non-qualified stock option awards to pur...
Positive
Seeking Alpha
11 days ago
We added key positions in Masimo, Exact Sciences, Eli Lilly, Penumbra, and Edwards Lifesciences, each with strong growth drivers and market leadership. Our investment in Masimo is supported by divestiture of non-core assets, new leadership, and a focus on high-growth hospital monitoring technologies. Eli Lilly remains a core holding due to its leadership in diabetes and obesity treatments, robu...
Neutral
Business Wire
14 days ago
SAN FRANCISCO--(BUSINESS WIRE)---- $GH--The American Cancer Society (ACS) today announced a new partnership with Guardant Health (Nasdaq: GH), a leading precision oncology company focused on improving access to cancer screening and advancing health equity. This collaboration supports ACS's nationwide cancer screening efforts, including the I Love You, Get Screened public awareness campaign; com...
More Guardant Health, Inc. News

Company Profile

Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA.

Head office United States
CEO Helmy Eltoukhy
Employees 2,010
Founded 2012
Website guardanthealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today